Stock Events

Stock Events

Greenbrook TMS 

$15.45
5
-$0.05-0.32% Monday 16:48

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
208.61M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

8NovExpected
Q3 2020
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
-0.59
-0.47
-0.34
-0.22
Expected EPS
-0.22
Actual EPS
-0.59

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.77B
Medtronic offers neuromodulation devices including those for brain stimulation, directly competing in the mental health treatment market.
Nutriband
NTRB
Mkt Cap54.22M
NeuroOne Medical Technologies develops technology for neurological disorders, competing in the broader neurostimulation and mental health market.
Roundhill Magnificent Seven
MAGS
Mkt Cap0
Magstim provides Transcranial Magnetic Stimulation equipment, directly competing in the TMS technology sector that Greenbrook operates in.
Brainsway
BWAY
Mkt Cap574.7M
Brainway Deep TMS is a provider of deep transcranial magnetic stimulation, competing in the same technology space as Greenbrook TMS.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie, through its acquisition of Allergan, has treatments for psychiatric conditions, indirectly competing with Greenbrook's TMS services.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly produces psychiatric medications, offering alternative treatments to TMS for conditions like depression.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries manufactures generic drugs including CNS treatments, providing alternative solutions to TMS.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its Janssen Pharmaceuticals division, offers medications for mental health, competing with TMS treatments indirectly.

About

Medical/Nursing Services
Health Services
Greenbrook TMS Inc., through its subsidiaries, manages a network of outpatient facilities across the United States that provide mental health services. These centers specialize in delivering Transcranial Magnetic Stimulation (TMS) therapy, an FDA-approved, non-invasive treatment for major depressive disorder and other mental health conditions, along with related psychiatric care. As of December 31, 2021, the company operated 94 wholly-owned and 55 TMS centers in various locations including Virginia, Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and has its corporate headquarters in Toronto, Canada.
Show more...
CEO
William P. Leonard
Employees
644
Country
Canada
ISIN
CA3937043097

Listings

TO
CA
GTMS.TO

0 Comments

Share your thoughts

FAQ

What is Greenbrook TMS stock price today?▼
The current price of GBOKF is $15.45 USD — it has decreased by -0.32% in the past 24 hours. Watch Greenbrook TMS stock price performance more closely on the chart.
What is Greenbrook TMS stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange Greenbrook TMS stocks are traded under the ticker GBOKF.
What is Greenbrook TMS market cap?▼
Today Greenbrook TMS has the market capitalization of 208.61M
What were Greenbrook TMS earnings last quarter?▼
GBOKF earnings for the last quarter are -0.25 USD per share, whereas the estimation was -0.32 USD resulting in a +21.88% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Greenbrook TMS have?▼
As of September 05, 2026, the company has 644 employees.
In which sector is Greenbrook TMS located?▼
Greenbrook TMS operates in the Health & Wellness sector.
When did Greenbrook TMS complete a stock split?▼
Greenbrook TMS has not had any recent stock splits.
Where is Greenbrook TMS headquartered?▼
Greenbrook TMS is headquartered in Toronto, Canada.